The Best of ASCO – Memphis

Posted by & filed under Uncategorized.

West Medical Oncologists, Dr. Bradley Somer and Dr. Gregory Vidal are two of the presenters for the upcoming Best of ASCO – Memphis Conference. Dr. Vidal will host two sessions: the SEEK Workshop Primer Panel and Diversity in Cancer Care, while Dr. Somer will host a session on GU Cancers. This Post ASCO Review will… Read more »

Key Risk Factors Affecting Treatment Choice in Melanoma with Dr. G. Gary Tian

Posted by & filed under Uncategorized.

Key Risk Factors Affecting Treatment Choice in Melanoma   West provider, Dr. G. Gary Tian, joins Dr. Evan J. Lipson with John Hopkins Medicine and other oncology experts to discuss critical factors influencing physicians’ decisions between monotherapy and doublet therapy for Metastatic Melanoma.   The group dives into the latest treatment options for metastatic melanoma,… Read more »

Standard-of-Care Treatment Approaches for HR+/HER2 Early Breast Cancer ft. Dr. Gregory Vidal

Posted by & filed under Uncategorized.

In a recent OncLive Peer Exchange, Dr. Gregory Vidal partnered with a panel of breast oncology experts to discuss the standard-of-care treatment approaches for early-stage HR-positive/HER2-negative breast cancer.   Topics include: – Evolution of HER2-negative management – Updates in HR-positive treatment – Importance of genetic testing – Utilization of endocrine therapy – BRCA mutations and… Read more »

Meet Judy: Esophageal Cancer Survivor

Posted by & filed under Uncategorized.

Meet Judy: Esophageal Cancer Survivor   Judy came to our West family after she and her husband moved from Florida to Memphis post-retirement. While in Florida, Judy was at high risk for developing esophageal cancer and received frequent screenings to ensure early detection. She was ultimately diagnosed with Stage IV esophageal cancer and would have… Read more »

Updates in GI Cancers with Dr. Axel Grothey

Posted by & filed under Uncategorized.

Exciting updates in GI Cancers! Dr. Axel Grothey from West Cancer Center shared groundbreaking insights at the Total Health Spring Oncology Review and Renew Conference. He highlighted major advancements in targeted therapies and precision medicine for GI cancers. Here are the key highlights: Gastro-Esophageal Junction (GEJ) Cancers: Dr. Grothey revealed a new biomarker, Claudin 18.2… Read more »

Cancer Updates: Free Dinner Series for Regional Providers

Posted by & filed under Uncategorized.

CALLING ALL REGIONAL PROVIDERS From now through November, our West family is partnering with Total Health Conferencing to host “Cancer Updates: A Dinner Series for Community Care Teams.” These dinners will consist of educational discussions designed for oncologists, pharmacists, advanced practitioners, and nurses involved in the treatment of various cancers. Each tumor-focused program is comprised… Read more »

100% Response Rate in Skin Cancer Trial

Posted by & filed under Uncategorized.

Our West family is 1 of only 2 sites across the country to host this clinical trial for patients with recurrent or unresectable skin cancers. “After 12 weeks post-treatment, complete response was observed in all 10 patients (100%)! CT scans at 24 weeks post-treatment showed NO EVIDENCE OF RECURRENT DISEASE in any of the patients.”… Read more »

Head & Neck Cancers

Posted by & filed under Uncategorized.

The treatment of head and neck cancers involves both eliminating the cancer and providing the latest reconstructive procedures to restore patients’ appearance plus ability to swallow and speak. At West Cancer Center & Research Institute we have a team of specialists in medical oncology, radiation oncology,  radiology, pathology, plastic & reconstructive surgery, psychology, speech therapy,... Read more »

Dr. Noam VanderWalde on Geriatric Oncology

Posted by & filed under Uncategorized.

Geriatric Oncology is a strong field of interest for our Radiation Oncologist and Co-Director of Clinical Research, Dr. Noam VanderWalde. In this podcast, he discusses the importance of personalization for older cancer patients alongside Dr Akila Viswanathan (Johns Hopkins Medicine) and Dr Ben Movsas (Henry Ford Cancer Institute – Detroit). Click here to listen!

Sarcoma

Posted by & filed under Uncategorized.

Although sarcomas are rare, representing only 1% of cancer types, at West Cancer Center & Research Institute, we have a team that specializes in treating this form of cancer. Our sarcoma team manages soft tissue tumors, which comprise approximately 80% of all sarcomas and bone tumors. Our multidisciplinary team works together to diagnosis the specifics... Read more »